Julia M Carlson1, Eric W Etchill2, Clare Angeli G Enriquez3, Anna Peeler4, Glenn J Whitman2, Chun Woo Choi2, Romergryko G Geocadin5, Sung-Min Cho6. 1. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. 2. Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. 3. Department of Neurosciences, University of the Philippines Manila-Philippine General Hospital, Manila, Philippines. 4. Johns Hopkins University School of Nursing, Baltimore, MD. 5. Division of Neuroscience Critical Care, Departments of Neurology and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 6. Division of Neuroscience Critical Care, Departments of Neurology and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: csungmi1@jhmi.edu.
Abstract
OBJECTIVE: As survival with extracorporeal membrane oxygenation (ECMO) therapy improves, it is important to study patients who do not survive secondary to withdrawal of life-sustaining therapy (WLST). The purpose of the present study was to determine the population and clinical characteristics of those who experienced short latency to WLST. DESIGN: Retrospective cohort study. SETTING: Single academic hospital center. PARTICIPANTS: Adult ECMO patients. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: During the study period, 150 patients (mean age 54.8 ± 15.9 y, 43.3% female) underwent ECMO (80% venoarterial ECMO and 20% venovenous ECMO). Seventy-three (48.7%) had WLST from ECMO support (median five days), and 33 of those (45.2%) had early WLST (≤five days). Patients who underwent WLST were older (60.3 ± 15.3 y v 49.6 ± 14.7 y; p < 0.001) than those who did not undergo WLST and had greater body mass index (31.7 ± 7.6 kg/m2v 28.3 ± 5.5 kg/m2; p = 0.002), longer ECMO duration (six v four days; p = 0.01), and higher Acute Physiology and Chronic Health Evaluation (25 v 21; p < 0.001) and Sequential Organ Failure Assessment (12 v 11; p = 0.037) scores. Family request frequently (91.7%) was cited as part of the WLST decision. WLST patients experienced more chaplaincy (89% v 65%; p < 0.001), palliative care consults (53.4% v 29.9%; p = 0.003), and code status change (do not resuscitate: 83.6% v 7.8%; p < 0.001). CONCLUSIONS: Nearly 50% of ECMO patients underwent WLST, with approximately 25% occurring in the first 72 hours. These patients were older, sicker, and experienced a different clinical context. Unlike with other critical illnesses, neurologic injury was not a primary reason for WLST in ECMO patients.
OBJECTIVE: As survival with extracorporeal membrane oxygenation (ECMO) therapy improves, it is important to study patients who do not survive secondary to withdrawal of life-sustaining therapy (WLST). The purpose of the present study was to determine the population and clinical characteristics of those who experienced short latency to WLST. DESIGN: Retrospective cohort study. SETTING: Single academic hospital center. PARTICIPANTS: Adult ECMO patients. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: During the study period, 150 patients (mean age 54.8 ± 15.9 y, 43.3% female) underwent ECMO (80% venoarterial ECMO and 20% venovenous ECMO). Seventy-three (48.7%) had WLST from ECMO support (median five days), and 33 of those (45.2%) had early WLST (≤five days). Patients who underwent WLST were older (60.3 ± 15.3 y v 49.6 ± 14.7 y; p < 0.001) than those who did not undergo WLST and had greater body mass index (31.7 ± 7.6 kg/m2v 28.3 ± 5.5 kg/m2; p = 0.002), longer ECMO duration (six v four days; p = 0.01), and higher Acute Physiology and Chronic Health Evaluation (25 v 21; p < 0.001) and Sequential Organ Failure Assessment (12 v 11; p = 0.037) scores. Family request frequently (91.7%) was cited as part of the WLST decision. WLST patients experienced more chaplaincy (89% v 65%; p < 0.001), palliative care consults (53.4% v 29.9%; p = 0.003), and code status change (do not resuscitate: 83.6% v 7.8%; p < 0.001). CONCLUSIONS: Nearly 50% of ECMO patients underwent WLST, with approximately 25% occurring in the first 72 hours. These patients were older, sicker, and experienced a different clinical context. Unlike with other critical illnesses, neurologic injury was not a primary reason for WLST in ECMO patients.
Authors: Maximilian Mulder; Haley G Gibbs; Stephen W Smith; Ramnik Dhaliwal; Nathaniel L Scott; Mark D Sprenkle; Romergryko G Geocadin Journal: Crit Care Med Date: 2014-12 Impact factor: 7.598
Authors: Erin S DeMartino; Nicholas A Braus; Daniel P Sulmasy; J Kyle Bohman; John M Stulak; Pramod K Guru; Kayla R Fuechtmann; Nausheen Singh; Gregory J Schears; Paul S Mueller Journal: Mayo Clin Proc Date: 2019-03-08 Impact factor: 7.616
Authors: Sarah M Perman; James N Kirkpatrick; Angelique M Reitsma; David F Gaieski; Bonnie Lau; Thomas M Smith; Marion Leary; Barry D Fuchs; Joshua M Levine; Benjamin S Abella; Lance B Becker; Raina M Merchant Journal: Crit Care Med Date: 2012-03 Impact factor: 7.598
Authors: Alexander Sacha C Richardson; Matthieu Schmidt; Michael Bailey; Vincent A Pellegrino; Peter T Rycus; David V Pilcher Journal: Resuscitation Date: 2016-12-16 Impact factor: 5.262
Authors: Ibrahim Migdady; Cory Rice; Abhishek Deshpande; Adrian V Hernandez; Carrie Price; Glenn J Whitman; Romergryko G Geocadin; Sung-Min Cho Journal: Crit Care Med Date: 2020-07 Impact factor: 7.598
Authors: Julia M Carlson; Eric Etchill; Glenn Whitman; Bo Soo Kim; Chun Woo Choi; Joseph E Tonna; Romergryko Geocadin; Sung-Min Cho Journal: Resuscitation Date: 2022-08-04 Impact factor: 6.251